Gibralt Capital Corporation
3
24M
2
0.10
1
0.33
1
- Stages of investment
- Areas of investment
Summary
Gibralt Capital Corporation appeared to be the VC, which was created in 1992. The company was established in North America in Canada. The leading representative office of defined VC is situated in the Vancouver.
The common things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2005. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2014.
Among the most popular portfolio startups of the fund, we may highlight Epirus Biopharmaceuticals. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund. Among the most popular fund investment industries, there are Internet, Biotechnology.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Gibralt Capital Corporation, startups are often financed by Montreux Equity Partners, 5AM Ventures. The meaningful sponsors for the fund in investment in the same round are TPG Biotech, Mousse Partners, Montreux Equity Partners.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 1
- Exits
- 1
- Rounds per year
- 0.10
- Follow on index
- 0.33
- Investments by industry
- Life Science (2)
- Biotechnology (2)
- Therapeutics (2)
- Security (1)
- Information Technology (1) Show 3 more
- Investments by region
-
- United States (2)
- Canada (1)
- Peak activity year
- 2014
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 22
- Group Appearance index
- 0.67
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| 16 Apr 2014 | Biotechnology, Life Science, Therapeutics | Early Stage Venture | 36M | United States, Massachusetts, Boston |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.